0001992190-23-000001.txt : 20230908 0001992190-23-000001.hdr.sgml : 20230908 20230908153551 ACCESSION NUMBER: 0001992190-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230908 DATE AS OF CHANGE: 20230908 EFFECTIVENESS DATE: 20230908 FILER: COMPANY DATA: COMPANY CONFORMED NAME: O'Ryan Therapeutics, Inc. CENTRAL INDEX KEY: 0001992190 IRS NUMBER: 932259367 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-491695 FILM NUMBER: 231245128 BUSINESS ADDRESS: STREET 1: 33 KIRKLAND CIRCLE CITY: WELLESLEY STATE: MA ZIP: 02481 BUSINESS PHONE: 617-943-9983 MAIL ADDRESS: STREET 1: 33 KIRKLAND CIRCLE CITY: WELLESLEY STATE: MA ZIP: 02481 D 1 primary_doc.xml X0708 D LIVE 0001992190 O'Ryan Therapeutics, Inc. 33 KIRKLAND CIRCLE WELLESLEY MA MASSACHUSETTS 02481 617-943-9983 DELAWARE None None Corporation true 2023 Michael Parnell 33 Kirkland Circle Wellesley MA MASSACHUSETTS 02481 Executive Officer Director Tim Coleman 33 Kirkland Circle Wellesley MA MASSACHUSETTS 02481 Executive Officer Director Other Health Care Decline to Disclose 06b false 2023-08-29 false true true false 0 600000 40000 560000 false 2 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false O'Ryan Therapeutics, Inc. Michael Parnell Michael Parnell President and CEO 2023-09-08